Concepedia

Tomoki Nakajima

TN

Statistics

Publications

34

Citations

1.6K

H-Index

22

Active since

1985

Affiliations

Kyoto Prefectural University of Medicine(Current)

Fukuyama City Hospital

Kyoto City Hospital

Saiseikai Suita Hospital

Kyoto first Red Cross hospital

Tomoki Nakajima is an author at Kyoto Prefectural University of Medicine specializing in medicine, oncology, and liver disease.

Publications per year

1985–2021

34

Publications

34

A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins

Taichiro Nishikawa, Tomoki Nakajima, Michihisa Moriguchi et al. · Journal of Hepatology · 2005 · 180 citations

Life Sciences, Oncology, Pharmacology +17

Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver

Yuichi Harano, Kohichiroh Yasui, Tetsuya Toyama et al. · Liver International · 2006 · 146 citations

Life Sciences, Biochemistry, Pharmacology +17

Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry

Hiroyuki Kimura, Tomoki Nakajima, Keizo Kagawa et al. · Liver International · 1998 · 115 citations

Medicine, Oncology, Pathology +17

The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin‐8 production

Michihisa Moriguchi, Tomoki Nakajima, Hiroyuki Kimura et al. · International Journal of Cancer · 2002 · 96 citations

Medicine, Oncology, Pharmacology +11

Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis

Masahito Minami, Yukiko Daimon, Kojiro Mori et al. · Oncogene · 2005 · 88 citations

Medicine, Genetics, Molecular Genetics +15

1–5 of 34